Studies showed that ANGPTL8 was positively correlated with the incidence of non-alcoholic fatty liver disease (NAFLD) and significantly elevated in mice and humans with NAFLD (45). This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.